ECONOMIC IMPACT OF EMICIZUMAB PROPHYLAXIS FOR HEMOPHILIA A WITH AND WITHOUT INHIBITORS

被引：0
|
作者：
Cortesi, P. A. [1 ]
Castaman, G. [2 ]
Mantovani, L. G. [1 ]
机构：
[1] Univ Milano Bicocca, Monza, Italy
[2] Azienda Osped Univ Careggi, Florence, Italy
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRO53
引用
收藏
页码：S699 / S699
页数：1
相关论文
共 50 条
  • [41] Prophylaxis for hemophilia A without inhibitors: treatment options and considerations
    Valentino, Leonard A.
    Khair, Kate
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (07) : 731 - 743
  • [42] FIRST NEUTRALIZING ANTIDRUG ANTIBODY TO EMICIZUMAB IN A PATIENT WITH SEVERE HEMOPHILIA A WITHOUT INHIBITORS
    Guerrera, Michael F.
    Kizilocak, Hande
    Varela, Carly
    Guelcher, Christine
    Godby, Lauren
    Young, Guy
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E43 - E43
  • [43] RECURRENT INHIBITORS OCCURRED ON EMICIZUMAB PROPHYLAXIS IN A CHILD WITH HEMOPHILIA A WITH INHIBITORS AFTER IMMUNE TOLERANCE INDUCTION: A CASE REPORT
    Li, Z.
    Liu, G.
    Wu, R.
    [J]. HAEMOPHILIA, 2023, 29 : 93 - 94
  • [44] Emicizumab: a novel drug in hemophilia A prophylaxis - a narrative review
    Mazurkiewicz, Lukasz
    Czernikiewicz, Krystian
    Rupa-Matysek, Joanna
    Gil, Lidia
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (10) : 933 - 942
  • [45] Breakthrough bleeding episodes in pediatric severe hemophilia a patients with and without inhibitors receiving emicizumab prophylaxis: a single-center retrospective review
    Hassan, Eman
    Motwani, Jayashree
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2022, 39 (05) : 418 - 426
  • [46] A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors
    Young, Guy
    Liesner, Ri
    Chang, Tiffany
    Sidonio, Robert, Jr.
    Oldenburg, Johannes
    Jimenez-Yuste, Victor
    Mahlangu, Johnny
    Kruse-Jarres, Rebecca
    Wang, Michael
    Uguen, Marianne
    Doral, Michelle Y.
    Wright, Lilyan Y.
    Schmitt, Christophe
    Levy, Gallia G.
    Shima, Midori
    Mancuso, Maria Elisa
    [J]. BLOOD, 2019, 134 (24) : 2127 - 2138
  • [47] Serious bleeds in pediatric persons with hemophilia A on emicizumab prophylaxis
    Garcia, Jessica
    Hammer, Matthew R.
    Zia, Ayesha
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (08)
  • [48] An Investigational Dosing Algorithm of Emicizumab for Prophylaxis in Acquired Hemophilia a
    Shima, Midori
    Nagami, Sayaka
    Yoneyama, Koichiro
    Nomura, Akira
    Ogawa, Yoshiyuki
    Amano, Kagehiro
    Nogami, Keiji
    [J]. BLOOD, 2020, 136
  • [49] Emicizumab Prophylaxis for the Treatment of Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Interim Analysis of the HAVEN 7 Study
    Pipe, Steven W.
    Collins, Peter
    Dhalluin, Christophe
    Kenet, Gili
    Schmitt, Christophe
    Buri, Muriel
    Jimenez-Yuste, Victor
    Peyvandi, Flora
    Young, Guy
    Oldenburg, Johannes
    Mancuso, Maria Elisa
    Kiialainen, Anna
    Chang, Tiffany
    Lehle, Michaela
    Fijnvandraat, Karin
    [J]. BLOOD, 2022, 140
  • [50] Hemophilia A in infantsEffective prophylaxis with emicizumab possible at an early stage
    Burggraf, Leoni
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2023, 50 (05)
12345